Research location

Viña del Mar

Valparaiso, Chile

Published trials129
Site observations140
Linked trials published129
Page3 / 3
Advertisement

Research activity in Viña del Mar

Valparaiso, Chile

CureCurrent currently publishes aggregate city-level research activity for this location: 129 trials and 140 site observations.

The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.

Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.

Trials with sites in Viña del Mar

129 linked trials · page 3 of 3
An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (mcg) , FF/VI 100/25 mcg, and FF 100 mcg in Adults and Adolescents With Persistent Asthma.NCT01686633 · 2012-09-20 · 1 site observation
COMPLETED
A Fixed Dose Study of Ropinirole Prolonged Release as Adjunctive Treatment in Patients With Advanced Parkinson's DiseaseNCT01494532 · 2012-04-02 · 1 site observation
COMPLETED
Trial in Extensive-Disease Small Cell Lung Cancer (ED-SCLC) Subjects Comparing Ipilimumab Plus Etoposide and Platinum Therapy to Etoposide and Platinum Therapy AloneNCT01450761 · 2011-12-13 · 1 site observation
COMPLETED
Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary DiseaseNCT01313676 · 2011-01-25 · 1 site observation
COMPLETED
Phase 3 Trial in Squamous Non Small Cell Lung Cancer Subjects Comparing Ipilimumab Versus Placebo in Addition to Paclitaxel and CarboplatinNCT01285609 · 2011-01-16 · 1 site observation
COMPLETED
A Phase 3, Multi Site, Randomized, Double Blind, Placebo Controlled Study Of The Efficacy And Safety Comparing CP- 690,550 And Etanercept In Subjects With Moderate To Severe Chronic Plaque PsoriasisNCT01241591 · 2010-11-01 · 1 site observation
COMPLETED
Phase 3 Study of Immunotherapy to Treat Advanced Prostate CancerNCT01057810 · 2010-07-01 · 1 site observation
COMPLETED
HZA113091 Efficacy and Safety of Fluticasone Furoate/Vilanterol (GW642444) in Adults and AdolescentsNCT01147848 · 2010-06-01 · 1 site observation
COMPLETED
Comparing The Effectiveness And Safety Of 2 Doses Of An Experimental Drug, CP-690,550, To Methotrexate (MTX) In Patients With Rheumatoid Arthritis Who Have Not Previously Received MTXNCT01039688 · 2010-01-01 · 1 site observation
COMPLETED
Study to Evaluate the Efficacy and Safety of GSK239512 in Alzheimer's DiseaseNCT01009255 · 2009-11-02 · 1 site observation
COMPLETED
A Study Comparing 2 Doses Of CP-690,550 Vs. Placebo For The Treatment Of Rheumatoid Arthritis In Patients On Other Background Arthritis MedicationsNCT00856544 · 2009-05-01 · 1 site observation
COMPLETED
Efficacy and Safety of Azilsartan Medoxomil Plus Chlorthalidone in Participants With Moderate to Severe HypertensionNCT00846365 · 2009-03-01 · 1 site observation
COMPLETED
Study of SB-742457 or Donepezil Versus Placebo in Subjects With Mild-to-moderate Alzheimer's DiseaseNCT00708552 · 2008-07-04 · 1 site observation
COMPLETED
A Study of SB-742457, Added to Donepezil for the Treatment of Mild-to-moderate Alzheimer's DiseaseNCT00710684 · 2008-07-01 · 1 site observation
COMPLETED
Investigating Clinical Efficacy of Ofatumumab in Adult Rheumatoid Arthritis (RA) Patients Who Had an Inadequate Response to MTX TherapyNCT00611455 · 2008-01-01 · 1 site observation
TERMINATED
Pazopanib Plus Lapatinib Compared To Lapatinib Alone In Subjects With Inflammatory Breast CancerNCT00558103 · 2007-12-01 · 1 site observation
COMPLETED
Study Of Rosiglitazone XR In Subjects With Mild-to-Moderate AlzheimersNCT00550420 · 2007-10-01 · 1 site observation
TERMINATED
Open-Label Extension Study Of Rosiglitazone XR As Adjunctive Therapy In Subjects With Mild-to-Moderate AlzheimersNCT00490568 · 2007-08-08 · 1 site observation
TERMINATED
Rosiglitazone (Extended Release Tablets) As Monotherapy In Subjects With Mild To Moderate Alzheimer's DiseaseNCT00428090 · 2007-02-27 · 1 site observation
COMPLETED
A 12-Week Study To Assess The Safety Of Fluticasone Propionate/Salmeterol 100/50 Hydrofluoroalkane (HFA) Versus Fluticasone Propionate 100 HFA In Children With AsthmaNCT00441441 · 2007-02-01 · 1 site observation
COMPLETED
Comparison Of 6 CP-690,550 Doses Vs.Placebo, Each Combined With Methotrexate, For The Treatment Of Rheumatoid ArthritisNCT00413660 · 2007-01-01 · 1 site observation
COMPLETED
An Oral p38 Inhibitor Investigating Safety, Efficacy, And PK In Subjects With Active Rheumatoid ArthritisNCT00383188 · 2006-12-15 · 1 site observation
COMPLETED
Tykerb Evaluation After Chemotherapy (TEACH): Lapatinib Versus Placebo In Women With Early-Stage Breast CancerNCT00374322 · 2006-08-01 · 1 site observation
COMPLETED
Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy For Subjects With Mild To Moderate Alzheimer's DiseaseNCT00348309 · 2006-07-06 · 1 site observation
COMPLETED
BMS-Reyataz Study in Treatment in Naive Subjects to Compare the Efficacy and Safety Between Boosted Reyataz and Kaletra When in Combination With Fixed Dose TruvadaNCT00272779 · 2005-11-01 · 1 site observation
COMPLETED
COX-2 Inhibitor Study In Patients With Rheumatoid ArthritisNCT00113308 · 2005-06-01 · 1 site observation
COMPLETED
"REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased RiskNCT00056407 · 2003-03-01 · 1 site observation
COMPLETED
Advair Pediatric Once-DailyNCT00920959 · 2001-11-01 · 1 site observation
COMPLETED
Rosiglitazone on Microalbuminuria in Type 2 DiabeticsNCT00500955 · 2000-04-01 · 1 site observation
COMPLETED
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.